Emerging Trends in Cell Banking (Technical Insights)
Emerging Trends in Cell Banking (Technical Insights)
Trends in Master and Working Cell Baking
29-Dec-2014
Global
$3,950.00
Special Price $2,962.50 save 25 %
Description
The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in drug discovery and development. On that note, cells and cell-based reagents constitute the foundations of most operational challenges. Indeed, cultured cells are frequently used to generate monoclonal antibodies (MAbs), enzymes, or substrates to be then utilized in other types of tests, such as ligand binding and enzymatic assays, thereby requiring distinct characterization and control measures to guarantee functional reliability over time.
The extreme sensitivity of cellular components to different chemical and physical elements and the possibility of alterations in the proteome expression profiles hold significant importance in assessing biopharmaceutical products. Therefore, the need for homogeneous, stable cell banks capable of safeguarding starting cellular material is substantial to perform reliable cell-based assays. Master and working cell banks (MCBs and WCBs) are established with the aim to provide a continuous source of viable cells that allow to generate accurate results for specific test methods.
This research service brings out the emerging trends in MCBs and WCBs on a global scale, through a detailed description of:
The technology capability and value chain; analysis of global technology trends.
An impact analysis of major drivers, restraints, and challenges influencing the growth of cell banks by timeframes.
An assessment of technology adoption and development, by region, demand side analysis, and recommendations for technology/product/services developers.
An evaluation of scenario modelling and emerging opportunities in MCBs and WCBs, technology management strategies and technology application roadmap.
A list of key patents of noteworthy innovations of global participants and a detailed list of key contacts in the field.
Table of Contents
Research Scope
Research Methodology
Key Findings
Technology Overview
Technology Process Overview
Technology Value Chain
Technology Capability
Technology Capability
Technology Capability
Technology Capability
Market Impact of Key Innovations
Market Impact of Key Innovations
Market Impact of Technology
Market Impact of Technology
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Technology Adoption Cycle
Scenario Modelling and Emerging Opportunities
Demand Side Analysis
Demand Side Analysis
Biophramas are increasing their partnerships with CMOs, for storing their proprietary cell lines and the development of novel cell lines.
Company Profiles (continued)
Company Profiles (continued)
Company Profiles (continued)
Company Profiles (continued)
Company Profiles (continued)
Key Contacts
Key Contacts (continued)
Key Contacts (continued)
Key Contacts (continued)
Patents
Patents (continued)
DSD–Government Healthcare Expenditure (Billion USD)
DSD–Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market
DSD–Pharmaceutical R&D Expenditure (Million USD)
DSD–Total Healthcare Expenditure (Billion USD)
DSD–Venture Capital Investment in Biotech R&D (Million USD)
Legal Disclaimer
Who is Frost & Sullivan
What Makes Us Unique
TEAM Methodology
Our Global Footprint 40+ Offices
Popular Topics
No Index | Yes |
---|---|
Podcast | No |
Author | Cecilia Van Cauwenberghe |
WIP Number | D567-01-00-00-00 |
Is Prebook | No |